Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)

Market Cap	2.78B -21.2%
Revenue (ttm)	826.15M +11.7%
Net Income	71.09M -15.2%
EPS	0.17 -15.2%
Shares Out	419.95M
PE Ratio	39.07
Forward PE	30.74
Dividend	0.04 (0.61%)
Ex-Dividend Date	Jun 3, 2026

Volume	6,647,943
Open	6.60
Previous Close	6.61
Day's Range	6.58 - 6.73
52-Week Range	6.11 - 9.48
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:300636

Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals in China and internationally. The company offers API products for anti-epilepsy and pain treatment, anti-inflammatory, gastrointestinal, anti-hypertension, anti-gout, anti-diabetes, anti-thrombotic, urology, non-alcoholic steatohepatitis, idiopathic parkinsonism, hypolipidemic agents, migraine therapy, prostate cancer, en...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2004
• Employees: 1,623
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300636

Financial Performance

In 2025, SHE:300636's revenue was 828.66 million, an increase of 9.19% compared to the previous year's 758.89 million. Earnings were 73.09 million, a decrease of -31.42%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 30, 2026

Data Sources Report a data error